Department of Ophthalmology, Pusan National University Yangsan Hospital, Geumo-ro 20, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 50612, South Korea.
Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Geumo-ro 20, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 50612, South Korea.
Sci Rep. 2021 Oct 6;11(1):19886. doi: 10.1038/s41598-021-99429-z.
This study aims to quantitatively investigate the optical coherence tomographic angiography (OCTA) findings of capillary congestion and its association with macular edema (ME) recurrence in chronic branch retinal vein occlusion (BRVO). We retrospectively reviewed the medical records of 115 consecutive patients with major ischemic BRVO who reached stable macula (without ME for two consecutive visits) at baseline (the first visit within the stable period). All patients were classified into a recurrence or non-recurrence groups depending on ME recurrence. Capillary congestion of deep capillary plexuses (DCP-C) and other abnormal capillary lesions were segmented, and their areas, vascular densities, and mean retinal thicknesses (MRT) were calculated. The main outcomes were differences between the two groups and risk factors for recurrence among baseline and OCTA parameters. A total of 76 eyes were included, of which 22 (28.9%) recurred. DCP-C existed in all eyes at baseline. MRT of DCP-C (p = 0.006) was greater in the recurrence group. Greater MRT of DCP-C (OR: 1.044; p = 0.002) and more frequent intravitreal injections (OR: 1.803; p < 0.001) were associated with a higher risk of relapsing ME. DCP-C may contribute to the anatomical stability of chronic BRVO and simultaneously be the source of ME.
本研究旨在定量研究毛细血管充血的光相干断层扫描血管造影 (OCTA) 表现及其与慢性分支视网膜静脉阻塞 (BRVO) 黄斑水肿 (ME) 复发的关系。我们回顾性分析了 115 例主要缺血性 BRVO 连续患者的病历,这些患者在基线时(稳定期内的首次就诊)达到稳定的黄斑(连续两次就诊均无 ME)。所有患者根据 ME 复发情况分为复发组或非复发组。对深层毛细血管丛 (DCP-C) 的毛细血管充血和其他异常毛细血管病变进行分割,并计算其面积、血管密度和平均视网膜厚度 (MRT)。主要结果是两组之间的差异以及基线和 OCTA 参数中复发的危险因素。共纳入 76 只眼,其中 22 只(28.9%)复发。基线时所有眼均存在 DCP-C。复发组 DCP-C 的 MRT 较大(p=0.006)。DCP-C 的更大 MRT(OR:1.044;p=0.002)和更频繁的玻璃体内注射(OR:1.803;p<0.001)与 ME 复发的风险增加相关。DCP-C 可能有助于慢性 BRVO 的解剖学稳定,同时也是 ME 的来源。